Lesion accumulation is predictive of long-term cognitive decline in multiple sclerosis

被引:19
|
作者
Ouellette, Russell [1 ,2 ]
Bergendal, Asa [3 ,4 ]
Shams, Sara [3 ,5 ]
Martola, Juha [3 ,5 ]
Mainero, Caterina [2 ,6 ]
Wiberg, Maria Kristoffersen [3 ,5 ]
Fredrikson, Sten [1 ,7 ]
Granberg, Tobias [2 ,3 ,5 ,6 ]
机构
[1] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
[2] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA
[3] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Med Imaging & Technol, Stockholm, Sweden
[4] Karolinska Univ Hosp, Dept Med Psychol, Stockholm, Sweden
[5] Karolinska Univ Hosp, Dept Radiol, Stockholm, Sweden
[6] Harvard Med Sch, Boston, MA USA
[7] Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden
关键词
Multiple sclerosis; Neuropsychological assessment; MRI; Assessment of cognitive disorders; WHITE-MATTER LESIONS; FOLLOW-UP; BRAIN ATROPHY; IMPAIRMENT; MRI; DYSFUNCTION; DISABILITY; RECOMMENDATIONS; DISCONNECTION; LOAD;
D O I
10.1016/j.msard.2018.03.002
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To investigate the long-term progression of cognitive dysfunction and its neuroanatomical correlates and predictors in multiple sclerosis (MS). Methods: A cohort of 37 MS patients reflecting five decades of disease duration and all subtypes was followed over 17.5 years. Matched controls were recruited at the last follow-up. Global cognitive functioning was assessed using a principal component cognitive index based on comprehensive neuropsychological testing. During the last 8.5 years of the study, brain MRI was performed to analyze normalized volumetrics of three global tissue compartments (white and gray matter, lesions) and strategic regions (corpus callosum, thalamus, hippocampus). Results: Cognitive decline progressed continuously throughout the study paralleled by atrophy and lesion accumulation. The cognitive index partly correlated with Expanded Disability Status Scale (p = -0.47, p < 0.001) and was mainly associated with the lesion fraction (beta = -0.48, p < 0.001) and callosal fraction (beta = 0.39, p = 0.002) in multiple linear regression analysis. The lesion fraction was an independent predictor of the cognitive performance 8.5 years later (beta = -0.35, p = 0.008). Symbol Digit Modalities Test was most frequently abnormal (40%), while Rey-Osterrieth Complex Figure Test was more sensitive to detect cognitive decline. Conclusions: Cognitive impairment progresses continuously in MS, associated with atrophy and lesion accumulation, suggesting that interventions targeting these processes could be beneficial at all disease stages. Widespread cognitive functions are more profoundly affected, associated with lesions and corpus callosal atrophy, supporting the idea of an underlying disconnection mechanism for cognitive decline in MS.
引用
收藏
页码:110 / 116
页数:7
相关论文
共 50 条
  • [21] Unfolding the long-term pathophysiological processes following an acute inflammatory demyelinating lesion of multiple sclerosis
    Zaaraoui, Wafaa
    Rico, Audrey
    Audoin, Bertrand
    Reuter, Francoise
    Malikova, Irina
    Soulier, Elisabeth
    Viout, Patrick
    Le Fur, Yann
    Confort-Gouny, Sylviane
    Cozzone, Patrick J.
    Pelletier, Jean
    Ranjeva, Jean-Philippe
    MAGNETIC RESONANCE IMAGING, 2010, 28 (04) : 477 - 486
  • [22] Monitoring long-term treatments in multiple sclerosis
    Filippi, Massimo
    Rocca, Maria A.
    NATURE REVIEWS NEUROLOGY, 2010, 6 (08) : 421 - 422
  • [23] Long-term outcomes in patients with multiple sclerosis
    Bates, David
    NEUROLOGY, 2011, 76 (01) : S1 - S2
  • [24] LONG-TERM TREATMENT OF MULTIPLE SCLEROSIS WITH CORTICOTROPHIN
    MILLAR, JHD
    VAS, CJ
    NORONHA, MJ
    LIVERSED.LA
    RAWSON, MD
    LANCET, 1967, 2 (7513): : 429 - &
  • [25] Prediction of long-term disability in multiple sclerosis
    Schlaeger, R.
    D'Souza, M.
    Schindler, C.
    Grize, L.
    Dellas, S.
    Radue, E. W.
    Kappos, L.
    Fuhr, P.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (01) : 31 - 38
  • [26] Corticosteroids for the long-term treatment in multiple sclerosis
    Ciccone, A.
    Beretta, S.
    Brusaferri, F.
    Galea, I
    Protti, A.
    Spreafico, C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (01):
  • [27] Multiple sclerosis - Long-term experiences with Glatirameracetate
    Stiefelhagen, Peter
    PSYCHOPHARMAKOTHERAPIE, 2006, 13 (06): : 263 - 264
  • [28] The importance of long-term data in multiple sclerosis
    Montalban, Xavier
    JOURNAL OF NEUROLOGY, 2006, 253 (Suppl 6) : 9 - 15
  • [29] Long-term unmet needs in multiple sclerosis
    Moore, H. L. J.
    Abu Baker, A. M.
    Baster, K.
    Hobson, E.
    Paling, D.
    Sharrack, B.
    Nair, K. P. S.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 722 - 723
  • [30] Long-term ocrelizumab in progressive multiple sclerosis
    Rose, Deja R.
    Cohen, Jeffrey A.
    LANCET NEUROLOGY, 2020, 19 (12): : 966 - 968